AK Medical Holdings (HKSE:01789) ROCE % : 5.93% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AK Medical Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 5.93%.

AK Medical Holdings ROCE % Historical Data

The historical data trend for AK Medical Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings ROCE % Chart

AK Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

31.63

23.67

5.30

10.41

9.50

AK Medical Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial													-2.06	13.54	7.84	13.11	5.93

AK Medical Holdings ROCE % Calculation

AK Medical Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	254.199	/	( ( (3098.316 - 487.316)	+	(3284.644 - 544.891) )	/ 2 )
	=	254.199	/	( (2611	+	2739.753)	/ 2 )
	=	254.199	/	2675.3765
	=	9.50 %

AK Medical Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	160.9	/	( ( (3390.477 - 699.544)	+	(3284.644 - 544.891) )	/ 2 )
	=	160.9	/	( ( 2690.933	+	2739.753 )	/ 2 )
	=	160.9	/	2715.343
	=	5.93 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

AK Medical Holdings (HKSE:01789) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

AK Medical Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

AK Medical Holdings (HKSE:01789) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200

Website

https://www.ak-medical.net/index.html

AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines